Where is Recordati located?
Recordati S.p.A., an international pharmaceutical enterprise dedicated to the research, development, manufacturing, and marketing of innovative treatments for rare diseases as well as specialized primary care medications, has its primary global corporate headquarters located in Milan, Italy. The central executive administrative offices are situated along Via Matteo Bandello in Milan. From this Italian financial and medical hub, the enterprise coordinates an extensive worldwide network of production plants, scientific research laboratories, and commercial distribution subsidiaries operating across Europe, the Americas, and Asia.
Related FAQs
Recordati's corporate mission focuses on reducing the severe impact of rare and devastating diseases by discovering, developing, and providing urgently needed specialty medicines in key therapeutic areas.
Recordati S.p.A. is an international pharmaceutical enterprise specializing in rare diseases, specialty primary care medications, and orphan drugs.
Recordati S.p.A. generates annual consolidated net revenues exceeding €2.2 billion to over €2.4 billion (translating to multi-billion-euro financial metrics), confirming its prominent standing as an international specialty pharmaceutical group.
Recordati S.p.A. is an international pharmaceutical group headquartered in Milan, Italy, dedicated to the research, development, manufacturing, and commercialization of specialized healthcare products.
Interest rates provided by the Bank of Mauston fluctuate according to specific deposit product tiers, compounding schedules, and prevailing monetary policy adjustments set by central banking authorities.
The global pharmaceutical market features blockbuster medications that generate tens of billions of dollars in annual sales revenue driven by high patient demand and broad therapeutic indications.
The Menarini Group, headquartered in Florence, is recognized as the largest Italian pharmaceutical company and a major global healthcare enterprise.
Recordati S.p.A. was founded in 1926 by Giovanni Recordati in Correggio, Italy, initially starting as a small pharmaceutical laboratory dedicated to researching and manufacturing medicinal preparations.
Recordati S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A., an international pharmaceutical group listed on the Borsa Italiana, maintains a market capitalization fluctuating around €10.4 billion to €10.6 billion (equivalent to approximately ₹1.
Recordati S.p.A.